Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/1/2001
 
First Published:
3/1/2000
1.
Phase I Study of BMS-214662 in Patients With Advanced Solid Tumors (Summary Last Modified 01/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
MSKCC-99045
BMS-CA158-004, NCI-G00-1671, NCT00004877
Last Modified:
7/12/2007
 
First Published:
7/1/2000
2.
Phase I Study of BMS-214662 in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia in Blast Phase (Summary Last Modified 06/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
15 and over
NCI
MDA-DM-99290
NCI-450, NCT00006213, 450
Last Modified:
7/12/2004
 
First Published:
7/1/2000
3.
Phase I Study of BMS-214662 in Patients With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
Any age
NCI
MDA-ID-99304
NCI-671, 671, NCT00005973
Last Modified:
7/1/2002
 
First Published:
7/1/2000
4.
Phase I Study of Paclitaxel and BMS-214662 in Patients With Advanced Solid Tumors (Summary Last Modified 07/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
CWRU-4Y99
NCI-290, NCT00006018, 290
Last Modified:
9/13/2005
 
First Published:
9/1/2000
5.
Phase I Study of BMS-214662 in Patients With Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
DFCI-00003
NCI-67, NCT00006242, 67
Last Modified:
1/31/2004
 
First Published:
8/1/2001
6.
Phase I Study of BMS-214662 and Trastuzumab (Herceptin) in Patients With Advanced Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
FCCC-01013
NCI-139, NCT00022529, 139
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute